Cathie Wood made several trades across her ARK ETFs on Monday, December 22, according to daily trade filings. The moves showed continued selling in Tesla (TSLA), the electric-vehicle maker, and fresh cuts in Rocket Lab (RKLB), the space launch company. At the same time, ARK added to positions in Oklo (OKLO), a nuclear energy firm, Archer Aviation (ACHR), an electric aircraft developer, and several biotech stocks.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Why Is Cathie Wood Selling Tesla and Rocket Lab Stocks?
On the sell side, ARK continued to scale back its position in Tesla. The firm sold 60,715 shares of TSLA, valued at about $29.2 million. The move follows last week’s sale of more than 124,000 shares, signaling a gradual reduction in exposure rather than a full exit.
Tesla stock has been volatile, as investors weigh progress in autonomous driving against valuation concerns after the recent rally. Even so, shares finished Monday up 1.56% at $488.73, showing that investor interest remains strong even as ARK locked in some gains.
ARK also cut back its stake in Rocket Lab, selling 232,425 shares worth roughly $16.4 million. The move marks a notable reduction in the space stock as the fund appears to be capitalizing on the recent surge in RKLB shares. Notably, Rocket Lab stock hit a new 52-week high on Monday as investor confidence rose around its faster launch pace, new government contracts, and a larger role in the commercial space market. With shares up more than 205% year to date, ARK’s sale suggests profit-taking after a strong run.
Beyond Tesla and Rocket Lab, ARK also reduced exposure to consumer and streaming technology names. The fund sold 33,164 shares of Shopify (SHOP) for about $5.6 million and 40,217 shares of Roku (ROKU) worth roughly $4.4 million, pointing to ongoing portfolio rebalancing within its technology holdings.
Let’s see how the stocks ARK sold stack up on TipRanks.
ARK Buys Oklo, Archer Aviation, and Biotech Stocks
On the buying side, ARK added to Oklo, purchasing 107,321 shares through its ARK Autonomous Technology & Robotics ETF (ARKQ) for about $8.9 million. The move shows ARK’s rising interest in nuclear power as long-term energy needs continue to grow.
ARK also increased its aviation exposure by buying 446,848 shares of Archer Aviation, valued at roughly $3.6 million. In addition, the fund bought 520,697 shares of WeRide (WRD) for about $4.6 million, adding to its focus on future transport.
In the biotech space, ARK added 798,771 shares of Pacific Biosciences (PACB) for about $1.5 million and bought 787,793 shares of CRISPR Therapeutics (CRSP) worth roughly $4.4 million. The fund also picked up 187,880 shares of Intellia Therapeutics (NTLA), valued at about $1.7 million, keeping its focus on genomics and gene-editing tools.
Here’s how the stocks ARK bought compare on TipRanks.
